January 24, 2018 / 1:32 PM / 6 months ago

BRIEF-Lartruvo (Olaratumab) Approved In Canada For The Treatment Of Advanced Soft Tissue Sarcoma In Adults

Jan 24 (Reuters) - Eli Lilly And Co:

* LARTRUVO(OLARATUMAB) APPROVED IN CANADA FOR THE TREATMENT OF ADVANCED SOFT TISSUE SARCOMA IN ADULTS

* ELI LILLY CANADA INC - HEALTH CANADA HAS ISSUED NOTICE OF COMPLIANCE WITH CONDITIONS FOR LARTRUVO

* ELI LILLY CANADA - CONFIRMATORY PHASE 3 TRIAL IS CURRENTLY UNDERWAY TO FURTHER VERIFY CLINICAL BENEFIT OF OLARATUMAB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below